{
    "Title": "A Four-Point Screening Method for Assessing Molecular Mechanism of Action (MMOA) Identifies Tideglusib as a Time-Dependent Inhibitor of Trypanosoma brucei GSK3\u03b2",
    "URL": "https://doi.org/10.1371/journal.pntd.0004506",
    "Published": "March 4, 2016",
    "Subject_Areas": [
        "Trypanosoma",
        "Competitive inhibitors",
        "Trypanosoma brucei gambiense",
        "Enzyme inhibitors",
        "Chemical dissociation",
        "Drug discovery",
        "Trypanosoma brucei",
        "Drug therapy"
    ],
    "Authors": {
        "Zachary T. Swinney": [
            "Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America"
        ],
        "Brad A. Haubrich": [
            "Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America"
        ],
        "Shuangluo Xia": [
            "Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America"
        ],
        "Chakk Ramesha": [
            "Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America"
        ],
        "Stephen R. Gomez": [
            "Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America"
        ],
        "Paul Guyett": [
            "Department of Cellular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, United States of America"
        ],
        "Kojo Mensa-Wilmot": [
            "Department of Cellular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, United States of America"
        ],
        "David C. Swinney": [
            "Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America"
        ]
    }
}